Chanelle Pharma develops, registers, manufactures and out-licenses generic human pharmaceutical products.
The company has products across a broad therapeutic range in CNS, Cox-2 Inhibitors, Antihistamines, Cardio/anti-hypertensive, Dermatology, Diabetes and Osteoporosis.
Our commitment to excellence has made us a worldwide leader in contract development and manufacturing of generic pharmaceuticals.
Chanelle’s focus on innovation enables us to produce the highest quality medicines at highly competitive prices. We develop and manufacture over 2000 medicines that are commercialised under the labels of leading pharmaceutical companies worldwide.
Chanelle Pharma is a global company, exporting to 96 countries across the EU, Canada, Asia, Australia and the Middle East.
Our customers include major and indigenous generic pharmaceutical companies worldwide who purchase generic and Over-The-Counter (OTC) dossiers and finished product from Chanelle and agents/distributors whom we sell the Chanelle branded product to distribute in markets outside the EU
We base our competitive advantage in our flexibility, our people and our customer-focused-led attitude.